Diagnostic performance of 1,5-anhydroglucitol compared to 2-h glucose in the Atherosclerosis risk in communities study

Bethany Warren, Alexandra K. Lee, Christie M. Ballantyne, Ron C. Hoogeveen, James S. Pankow, Morgan Grams, Anna Köttgen, Elizabeth Selvin

Research output: Contribution to journalLetterpeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)1536-1537
Number of pages2
JournalClinical chemistry
Volume64
Issue number10
DOIs
StatePublished - Oct 2018

Bibliographical note

Funding Information:
tyne, Abbott, Roche Diagnostics; R.C. Hoo-geveen, Denka Seiken. Stock Ownership: None declared. Honoraria: None declared. Research Funding: The Atherosclerosis Risk in Communities study is carried out as a collaborative study supported by the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Department of Health and Human Services, under the following contracts: HHSN268201700001I, HHSN268201700003I, HHSN268201700 005I, HHSN268201700004I, HHSN2682 01700002I. Reagents for the 1,5-anhydroglucitol assays were donated by GlycoMark, Inc. B. Warren, NIH/NHLBI grant T32 HL007024; A.K. Lee, NIH/NHLBI grant T32 HL007024; E. Selvin, NIH/NIDDK grants K24DK10 6414 and R01DK089174. Expert Testimony: None declared. Patents: C.M. Ballantyne, 61721475.

Cite this